Why COPD flare-ups require careful oxygen and ventilation. A COPD exacerbation is an acute worsening of dyspnoea, cough and/or sputum over days that requires additional treatment. Infection, smoke, air pollution, heart failure, pulmonary embolism and pneumothorax may trigger or mimic it. The patient may be hypoxaemic and retain carbon dioxide; uncontrolled high-concentration oxygen can worsen hypercapnia in susceptible people. EMTs therefore combine ABCDE, controlled oxygen, bronchodilators, early clinician review, appropriate steroids/antibiotics and timely non-invasive ventilation (NIV). Follow current GOLD, Uganda Clinical Guidelines and local oxygen/NIV protocols.
1. Learning objectives
- Define COPD, chronic bronchitis, emphysema and an acute exacerbation.
- Recognise severe respiratory distress, hypercapnia, exhaustion and indications for NIV or intubation.
- Assess a deteriorating patient with ABCDE while considering pneumonia, heart failure, PE and pneumothorax.
- Explain controlled oxygen, inhaled bronchodilators, systemic corticosteroids, antibiotics and fluid safety.
- Plan monitoring, nursing care, discharge, smoking cessation, vaccination and pulmonary rehabilitation.
2. COPD and the exacerbation process
COPD causes persistent airflow limitation from small-airway inflammation, mucus, airway remodelling and destruction of alveolar attachments. Emphysema reduces gas-exchange surface area; chronic bronchitis increases mucus and cough. During an exacerbation, airway inflammation and secretions increase, expiratory flow falls, ventilation–perfusion mismatch worsens and respiratory muscles fatigue. Carbon dioxide retention may develop, producing headache, drowsiness, confusion and acidosis.
| Pattern | Clues |
|---|---|
| Chronic bronchitis phenotype | Long-term productive cough, frequent infective flare-ups and mucus burden. |
| Emphysema phenotype | Progressive exertional dyspnoea, hyperinflation, low body weight and reduced gas transfer. |
| Exacerbation | Acute increase in breathlessness, cough or sputum requiring additional treatment. |
| Acute-on-chronic respiratory failure | Hypoxaemia and/or hypercapnia with acidosis, exhaustion, altered mental state or inability to maintain ventilation. |
3. History and examination
- Time course and baseline: usual walking distance, home oxygen/NIV, previous blood gases, admissions, intubation and usual SpO₂.
- Symptoms: dyspnoea, cough, sputum volume/colour, fever, chest pain, haemoptysis, wheeze and ankle swelling.
- Triggers and comorbidity: smoking/biomass exposure, sick contacts, heart failure, diabetes, tuberculosis, PE risk, recent surgery and medication adherence.
- Medicines: inhaler devices, nebulisers, steroids, antibiotics, diuretics, opioids/sedatives and allergies.
- Examine work of breathing, posture, cyanosis, mental state, breath sounds, wheeze/crackles, JVP, oedema, calf swelling and signs of sepsis.
4. Severity and red flags
| Finding | Meaning | Action |
|---|---|---|
| Unable to speak, RR very high, marked accessory muscle use | Severe ventilatory load | Resuscitation area, controlled oxygen, bronchodilator and urgent senior review. |
| SpO₂ below local target, cyanosis | Hypoxaemia | Titrate oxygen and investigate pneumonia/PE/pneumothorax/heart failure. |
| New confusion, drowsiness, headache or asterixis | Possible hypercapnia or hypoxia | Blood gas if available, NIV/critical-care assessment; avoid sedatives. |
| Silent chest, exhaustion, poor respiratory effort | Impending arrest | Prepare assisted ventilation and urgent transfer/intubation team. |
| Shock, chest pain, arrhythmia, unilateral breath sounds | Alternative or additional emergency | ECG, targeted imaging and treat reversible cause urgently. |
5. ABCDE and first aid
| Step | Assessment | Immediate action |
|---|---|---|
| A – Airway | Speech, secretions, drowsiness and aspiration risk. | Suction if trained, upright positioning, airway adjuncts and early expert help. |
| B – Breathing | Rate, effort, chest movement, wheeze/crackles, SpO₂ and fatigue. | Controlled oxygen to prescribed target, nebulised bronchodilator, blood gas/NIV assessment. |
| C – Circulation | Pulse, BP, perfusion, ECG, oedema and dehydration. | IV access, cautious fluids only if indicated, treat shock, monitor arrhythmia. |
| D – Disability | GCS/AVPU, confusion, glucose, CO₂ narcosis. | Check glucose, avoid sedatives, escalate for ventilatory failure. |
| E – Exposure | Fever, sputum, oedema, calf signs, chest pain and infection source. | Keep warm, inspect for pneumonia/PE/heart failure and arrange targeted tests. |
6. Controlled oxygen
Oxygen is a medicine. Titrate to the local COPD target—commonly 88–92% for patients at risk of hypercapnic respiratory failure—unless the senior clinician specifies otherwise. Do not withhold oxygen from a critically hypoxaemic patient; give it, monitor closely and obtain blood gas/ventilatory support.
- Use a controlled device when available and record flow/device and response.
- Recheck SpO₂, respiratory effort, mental state and blood gas after oxygen changes.
- Worsening drowsiness, headache, flushed skin or acidosis suggests CO₂ retention, not “calm improvement.”
- Do not use a paper bag or allow a distressed patient to remove oxygen without assessment.
7. Medicines and emergency treatment
- Bronchodilators: nebulised or inhaled short-acting beta₂-agonist, often combined with ipratropium, according to the facility protocol. Monitor tachycardia, tremor and potassium.
- Systemic corticosteroid: prescribed early for moderate/severe exacerbation to shorten recovery and improve lung function; check glucose, infection risk and contraindications.
- Antibiotics: consider when bacterial infection is likely—particularly increased sputum purulence/volume, fever, pneumonia, severe exacerbation or need for ventilation. Use local antibiogram and stewardship principles.
- Fluids: correct dehydration cautiously; excessive fluid worsens pulmonary oedema and gas exchange.
- Analgesia/antipyretic: use safe non-sedating options; avoid opioids and sedatives that depress ventilation unless an expert airway team is controlling the airway.
- Diuretics/cardiac treatment: only if clinical evidence supports heart failure; do not label every crackle as COPD infection.
8. Non-invasive ventilation and advanced care
- NIV (usually bilevel positive-pressure ventilation) is standard first-line ventilatory support for suitable COPD patients with acute hypercapnic respiratory failure and acidosis.
- Use only with trained staff, a monitored setting, a cooperative patient able to protect the airway and rapid access to intubation if it fails.
- Explain the mask, check seal, protect pressure areas, provide breaks for secretions and monitor comfort, synchrony, respiratory rate, SpO₂, mental state and gas results.
- Do not use NIV in vomiting, severe facial trauma, untreated pneumothorax, cardiac/respiratory arrest, inability to protect the airway or severe agitation without expert review.
- Failure signs include worsening acidosis, hypoxaemia, exhaustion, haemodynamic instability, reduced consciousness or inability to tolerate the mask—call anaesthesia/critical care immediately.
- Intubation is high risk because hyperinflation can cause hypotension and barotrauma; it requires experienced clinicians and a low-rate, long-expiratory-time strategy.
9. Investigations
- Continuous/serial SpO₂, respiratory rate, pulse, BP, temperature, ECG and mental-state observations.
- Arterial or venous blood gas for severe disease, suspected CO₂ retention, acidosis or NIV assessment.
- Chest radiograph or ultrasound for pneumonia, oedema, pneumothorax, effusion or alternative diagnosis.
- FBC, electrolytes, urea/creatinine, glucose and inflammatory markers when they will change treatment.
- ECG/troponin for chest pain, arrhythmia or cardiac risk; D-dimer/CT only when PE assessment is clinically indicated.
- Sputum culture for severe, recurrent, resistant or treatment-failure disease; do not delay stabilisation.
10. Nursing and EMT care plan
| Problem | Care | Evaluate |
|---|---|---|
| Impaired gas exchange | Upright position, controlled oxygen, bronchodilator, NIV readiness and aspiration precautions. | Target SpO₂, blood gas, effort, speech, mental state and ventilatory trend. |
| Retained secretions | Hydration assessment, coached cough, suction when trained, sputum chart and physiotherapy referral. | Air entry, sputum volume/colour and work of breathing. |
| Medication risk | Check inhaler/nebuliser preparation, steroid/antibiotic indication, glucose/electrolytes and adverse effects. | Correct administration, improved symptoms and no toxicity. |
| Anxiety/fatigue | Stay with patient, explain NIV, conserve energy, provide rest and involve family safely. | Cooperation, reduced distress, sustained ventilation and nutrition. |
| Skin/nutrition | Pressure-area care under NIV mask, mouth care, small meals when safe, falls prevention. | Skin integrity, intake, mobility and functional recovery. |
11. Special populations and complications
- Older/frail patients: delirium and falls may be the first sign; review polypharmacy and advance-care preferences.
- Cardiac disease: distinguish COPD from pulmonary oedema; treat both if coexisting.
- Pregnancy: maintain maternal oxygenation and involve obstetric/respiratory specialists.
- Malnutrition: assess weight, muscle strength and refeeding risk during recovery.
- Complications: respiratory acidosis, arrhythmia, pneumothorax, pneumonia, PE, myocardial infarction, delirium, pressure injury and venous thromboembolism.
12. Discharge and prevention
- Confirm stable observations, safe oxygen plan, improving symptoms, ability to mobilise/eat and reliable follow-up.
- Check inhaler technique, adherence, spacer use, rescue plan and access to medicines.
- Support smoking cessation and reduce biomass smoke, occupational dust and indoor pollution.
- Offer influenza, pneumococcal and other locally recommended vaccines; manage nutrition and pulmonary rehabilitation.
- Teach early-warning symptoms: increasing dyspnoea, purulent sputum, fever, confusion, cyanosis or increased reliever use.
- Arrange review after the exacerbation and assess home oxygen/NIV need rather than starting oxygen without a plan.
13. Clinical scenarios
Scenario 1 – hypercapnic risk. A 70-year-old with COPD is drowsy, RR 30/min and SpO₂ 82% on room air. Give controlled oxygen to the local target, bronchodilator, urgent blood gas and senior review; worsening acidosis or consciousness requires NIV/critical care.
Scenario 2 – purulent exacerbation. A patient reports increased dyspnoea and green sputum with fever. Assess for pneumonia/sepsis, provide bronchodilator and prescribed steroid, obtain targeted tests and use antibiotics only when the clinician judges bacterial infection likely.
Scenario 3 – NIV failure. A patient on NIV becomes confused, hypotensive and unable to remove secretions. Call airway/critical care, prepare intubation and do not continue NIV unattended.
Scenario 4 – alternate diagnosis. Sudden pleuritic pain and unilateral absent breath sounds in a COPD patient suggests pneumothorax; treat the life threat and arrange urgent decompression/imaging rather than escalating nebulisers alone.
14. Common errors to avoid
- Giving uncontrolled high-flow oxygen without a target or reassessment in a known CO₂ retainer.
- Assuming every worsening is infection and prescribing antibiotics without clinical indication.
- Missing heart failure, PE, pneumothorax, pneumonia or myocardial infarction.
- Using sedatives/opioids to settle dyspnoea before airway and ventilation are secured.
- Starting NIV without monitoring, trained staff or a plan for failure.
- Discharging without inhaler review, smoking advice, follow-up and return precautions.
COPD flare check – “OXYGEN”
O – Observe ABCDE and alternative diagnoses
X – eXact oxygen target and serial blood gases
Y – Yield to bronchodilator, steroids and indicated antibiotics
G – Guard against CO₂ retention and fluid overload
E – Escalate early to NIV/critical care
N – Nursing, nutrition, prevention and follow-up
O – Observe ABCDE and alternative diagnoses
X – eXact oxygen target and serial blood gases
Y – Yield to bronchodilator, steroids and indicated antibiotics
G – Guard against CO₂ retention and fluid overload
E – Escalate early to NIV/critical care
N – Nursing, nutrition, prevention and follow-up
15. Revision questions
- Define a COPD exacerbation and list common triggers.
- Why can uncontrolled high-concentration oxygen be harmful in some COPD patients?
- List indications for blood gas analysis and NIV.
- Which clinical features suggest pneumonia, PE, pneumothorax or heart failure rather than uncomplicated COPD?
- When are steroids and antibiotics considered?
- Give six discharge and prevention measures after a COPD admission.
16. Key take-home points
- Assess COPD deterioration with ABCDE and search for reversible mimics.
- Titrate oxygen to a prescribed target, commonly 88–92% in patients at risk of hypercapnia.
- Bronchodilators, systemic steroids and selected antibiotics reduce the impact of an exacerbation.
- NIV is first-line ventilatory support for suitable acute hypercapnic respiratory failure, with a clear failure plan.
- Serial mental state, respiratory effort, blood gas and hemodynamics matter more than a single saturation.
Safety note: This is educational content for EMT students, not a prescription. Oxygen targets, steroid/antibiotic choice, nebuliser doses, NIV settings and intubation decisions must follow the current Uganda Ministry of Health/facility protocol and senior respiratory/critical-care supervision.
References for further study
- Global Initiative for Chronic Obstructive Lung Disease (GOLD): 2025 report
- WHO: COPD fact sheet
- NHLBI: COPD overview
- Uganda Ministry of Health: current respiratory, oxygen-therapy and emergency-care guidelines.